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ABSTRACT 
 
 Biomphalaria glabrata is an intermediate snail host for the digenean trematode, 
Schistosoma mansoni, which causes the human disease schistosomiasis. A lot of research has 
focused on the snail-schistosome interaction, especially in regards to the immune response of the 
snail. The nuclear factor-kappaB (NF-κB) pathway, which is involved in regulating the immune 
response, can be triggered by the Toll-like receptor (TLR) signaling pathway. However, not 
much is known about the specific molecular mechanisms regulating these responses. Both      
NF-κB and TLR homologues have recently been reported in B. glabrata so it is of great interest 
to determine if BgNF-κB can regulate components of the pathway. We have used bioinformatics 
to identify putative κB sites upstream of 16 genes coding for members of the TLR pathway in B. 
glabrata. In order to determine if the snail’s NF-κB p65 protein can recognize the κB sites of 
interest, electrophoretic mobility shift assays (EMSAs) were carried out. The functional analyses 
of putative κB sites are essential for advancing our understanding of the TLR mediated NF-κB 
pathway in B. glabrata. In the present study, six novel κB sites were characterized by showing 
that the Rel homology domain (RHD) of the B. glabrata NF-κB p65 protein could bind to these 
κB sites. Our findings suggest that BgNF-κB can regulate the expression of these genes. 
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INTRODUCTION 
1.1 Invertebrate immunology  
 Until recently, the field of immunology has largely focused on vertebrate systems (Rast 
& Messier-Solek, 2008). Vertebrates have both innate and adaptive immune systems, which 
allow organisms to respond to a vast array of foreign substances. The innate immune system 
serves as a first line of defense against pathogens, whereas the adaptive immune system can 
work to eliminate these foreign organisms during repeated infections (Owen et al. 2013). In 
contrast to vertebrate models, invertebrates rely solely on an innate immune system (Nyholm & 
Graf, 2012). However, invertebrates have highly diverse recognition receptors and effectors, as 
well as associated cell signaling pathways that can function through receptors. These various 
mechanisms allow invertebrates to recognize a variety of bacterial, viral, and fungal components 
on the surface of pathogens. Initial studies have revealed that invertebrate innate immune 
systems share many components that have also been reported in vertebrates (Schulenberg et al. 
2007). In 1996, Jules Hoffman, Bruno Lematire, and colleagues discovered that Toll was shown 
to be involved in the production of an antifungal peptide called drosomycin. This finding led to 
the discovery of mammalian Toll-like receptors, which has transformed our understanding of 
innate immunity in humans (Lemaitre et al. 1996). Their findings suggest that both invertebrate 
and vertebrate animals share common defense mechanisms, giving us further insight into our 
own innate immune systems. 
Despite their lack of antibody-based immune responses, invertebrates have been shown to 
exhibit highly effective immune responses (Table 1). Invertebrate animals have a vast array of 
antimicrobial peptides, which provide a rapid response to foreign microorganisms (Bulet et al. 
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2004). Other invertebrate defense mechanisms may include hemolymph coagulation and lectin-
mediated complement activation (Iwanaga & Lee, 2005). Additionally, many invertebrates have 
been shown to exhibit immunological memory, which allows organisms to respond more 
effectively to a pathogen upon repeated exposure. To illustrate, Kurtz and Franz (2003) found 
that a cyclopoid copepod (Macrocyclops albidus) could show increased immunity upon repeated 
exposure to a tapeworm (Schistocephalus solidus). Similarly, acquired immunological priming 
has been reported in the water flea (Daphnia magna), as well as a species of bumblebee (Bombus 
terrestrius) (Little et al. 2005; Sadd & Schmid-Hempel, 2006). These characteristics were 
previously thought to be unique to vertebrates with adaptive immunity, which suggests that 
invertebrates can indeed exhibit highly elaborate immune responses. 
Table 1. Major host defense systems in invertebrates. Table courtesy of Iwanaga and Lee (2005). 
Major host defense mechanisms 
Hemolymph coagulation system 
Pro-phenoloxidase (pro-PO) activating system 
Lectin-complement system 
Agglutinin-lectin system 
Antibacterial, antifungal, and antiviral systems mediated 
by Toll-like receptors (TLRs) and peptidoglycan-binding 
protein (PGBP) 
Reactive oxygen-producing system 
Phagocytic system 
 
1.2 Molluscan immunology 
Mollusks are considered as one of the most diverse phyla on the planet (Bunje, 2003). 
These animals display a wide array of defense mechanisms to protect themselves against 
pathogens and environmental stressors (Song et al. 2010). Most mollusks have physical (e.g., 
shells) and chemical (e.g., mucus) barriers to cover their soft bodies and defend against 
pathogens (Glinski & Jarosz, 1997). Similar to other invertebrates, mollusks rely exclusively on 
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an innate immune system that consists of two branches: the cellular response and the humoral 
response (Rowley & Powell, 2007). The former involves a variety of immune cells with different 
properties, such as the ability to engulf and isolate a respective pathogen. The humoral response 
consists of dissolved compounds (e.g., clotting factors, complement proteins, lectins) that 
circulate around the body and assist with pathogen elimination (Owen et al. 2013). These various 
components have contributed to the success of the phylum Mollusca. 
 Several molluscan species have already been widely researched, due to their role as 
intermediate hosts for parasites of medical and veterinary importance. For example, a number of 
Lymnaea species have been studied extensively due to their role as an intermediate host for a 
variety of trematode parasites, including the liver fluke (Fasciola hepatica), which causes serious 
infections in livestock (Roberts et al. 2012). Likewise, three genera of freshwater snails, 
Biomphalaria, Bulinus, and Oncomelania, can serve as the intermediate host for Schistosoma 
trematode parasites (World Health Organization, 1993). Schistosome infections affect over 261 
million people in 78 countries worldwide (Fig. 2; WHO, 2015). For these reasons, several 
molluscan species have been widely studied, particularly within the field of tropical medicine. 
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Figure 1. Worldwide distribution of schistosomiasis. Countries with reported cases of schistosomiasis are 
displayed above. Red regions are where both intestinal and urinary schistosomiasis can be reported. Purple 
regions indicate the presence of intestinal schistosomiasis only. Yellow regions show cases of urinary 
schistosomiasis only. Map was generated using data from the Centers for Disease Control and Prevention 
(2012). 
 
1.3 Schistosomiasis overview 
 As an intermediate host, the snail plays a critical role in the schistosome life cycle, as it 
allows the parasite to develop into the stage that is infectious to humans (Fig. 3; Boros, 1989). 
When free-swimming, ciliated larval stages called miracidia infect their compatible snail hosts, 
they shed their ciliary plates to transform into sporocysts. Then, they undergo multiple rounds of 
asexual reproduction, generating numerous mother and daughter sporocyst stages for four to six 
weeks (Colley et al. 2014). The sporocysts give rise to free-swimming, fork-tailed cercariae that 
are released from the snail into the water (Boros, 1989). Within freshwater, the cercariae can 
remain infective to their human hosts for one to three days (Colley et al. 2014). Upon contact 
with a human host, cercariae penetrate the skin, shedding their tails upon entry (CDC, 2012). 
Cercariae mature and transform into juvenile forms called schistosomulae, which migrate 
through the blood vessels from the lungs to the circulatory system (Boros, 1989). The 
schistosomulae reach maturity in the liver, where they develop into sexually dimorphic male and 
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female blood flukes. Here, the adults pair up and live in copula, where the slender female resides 
in the gynaecophoric canal of the broader male to form a “hot dog in a bun” arrangement (CDC, 
2012). Depending on the species of worm, the pair may relocate to the blood vessels of either the 
intestines or the bladder. Adults can live in the human host for an average of three to ten years, 
feeding on erythrocytes to harvest energy (Colley et al. 2014). Female worms can lay as many as 
300 eggs into the bloodstream per day (Boros, 1989). While most of these eggs are excreted into 
the surrounding freshwater through feces or urine to continue the life cycle, some of these eggs 
can become lodged inside the intestines, liver, or bladder, causing serious inflammatory 
responses (Boros, 1989; Colley et al. 2014). Eggs passed into the surrounding freshwater hatch 
into miracidia, which are the infectious stage to snails. The miracidia then infect a compatible 
snail host and the life cycle repeats.  
 
Figure 2. Schistosoma mansoni life cycle. 1) Eggs leave the human host via feces or urine. 2) Miracidia hatch 
in freshwater and enter the snail. 3) Sporocysts undergo multiple rounds of asexual reproduction and transform 
into cercariae. 4) Cercariae shed from the snail and pass into surrounding freshwater. 5) Cercariae penetrate 
human skin. 6) Juvenile worms (schistosomulae) migrate around the body in blood vessels. 7) Schistosomulae 
mature into adult male and female worms. 8) Adult worms pair up and reproduce; females lay eggs within the 
blood vessels. 
 Understanding the S. mansoni life cycle is imperative for the successful control and 
eradication of this tropical disease. In previous years, government officials have taken 
preventative measures to control disease transmission, mainly through mass drug administration 
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programs, molluscicides, and biological control (Gray, 2011). Anthelminthic drugs, e.g. 
praziquantel, are used to treat schistosome infections. However, infection rates remain relatively 
unchanged because the infectious snails are still present within areas where people can bathe and 
collect drinking water (Colley et al. 2014). In addition, people are susceptible to reinfection with 
schistosomes following drug treatment (Gryseels, 2006). 
1.4 Biomphalaria glabrata immune system 
In the field of parasitology, B. glabrata is one of the most extensively researched 
organisms, largely due to its critical role in the survival of S. mansoni (Fig. 4; Bayne et al. 1980; 
Matricon-Gondran & Letocart, 1999; Hahn et al. 2001; Guillou et al. 2007; Humphries & 
Yoshino, 2008; Adema et al. 2009). Strains within the species differ in their susceptibility to S. 
mansoni infection and are characterized as either resistant or susceptible (Yoshino & Cousteau, 
2011). Similar to other mollusks, the immune system of B. glabrata is comprised of both cellular 
and humoral components (Loker, 2004). Hemocytes (blood cells) circulate in the hemolymph, 
functioning as primary immune effector cells. These immune cells are released from the snail’s 
hematopoietic organ to kill foreign pathogens via phagocytosis or cellular encapsulation (Owen 
et al. 2013). Hemolymph serves as a vehicle for carrying humoral factors around the body. 
Humoral components may include lectins, clotting factors, free radicals, and a variety of 
fibrinogen-related proteins (FREPs) (Zhang et al. 2008).  
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Figure 3. Biomphalaria glabrata. Image courtesy of www.vectorbase.org. 
 
 Many studies have emphasized the importance of hemocytes and hemolymph for their 
ability to generate anti-schistosome responses (Hahn et al. 2001; Humphries & Yoshino et al. 
2008). For example, Hahn et al. (2001) examined the cytotoxic properties of hemocytes within 
susceptible and naturally resistant snail hosts. The authors in this study found that hemocytes in 
resistant snails can release free radicals, e.g. hydrogen peroxide (H2O2) and nitric oxide (NO), to 
kill sporocysts (Hahn et al. 2001). In contrast, susceptible snails were unable to use these defense 
strategies to kill the parasites and infection developed soon after parasite exposure. Other studies 
have been carried out to examine the protein profile of hemolymph before and after parasite 
infection (Adema et al. 1997; Zhang et al. 2008). 
Recent studies using reverse transcriptase-polymerase chain reaction (RT-PCR), 
suppressive subtractive hybridization (SSH), and gene profiling via microarrays have identified 
many differentially expressed transcripts following exposure to trematode parasites (Lockyer et 
al. 2002; Nowak et al. 2004; Mitta et al. 2005; Adema  et al. 2009). In fact significantly altered 
expression levels of various transcripts (e.g., defense-related lectins, sequences encoding 
histones) were reported in B. glabrata following S. mansoni exposure (Adema et al. 2009). 
Transcripts that show elevated expression levels following exposure to parasites are therefore 
hypothesized to play a role in defense.  
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 It is expected that such changes in gene expression within B. glabrata are regulated by an 
underlying mechanism; however, very little is currently known regarding gene regulation in the 
snail. In other species, it is known that gene expression can be regulated in part by transcription 
factors, which are DNA-binding proteins. Although many transcription factors are involved in 
generating immune responses within vertebrates, transcription factor homologues have only 
recently been identified in B. glabrata (Zhang & Coultas, 2011). Recently characterized 
transcription factors include signal transducer and activator of transcription (STAT), cyclic 
adenosine monophosphate response element-binding proteins (CREB), activator protein 1 (AP-
1), and lipopolysaccharide-induced tumor necrosis factor-α factor (LITAF) (Zhang & Coultas, 
2011; Adema et al. 2016). In addition, two members of the nuclear factor-kappaB (NF-κB) 
transcription factor family, Rel (GenBank Accession No: FJ804761) and Relish (GenBank 
Accession No: FJ804762), were recently identified in B. glabrata (Zhang & Coultas, 2011). 
1.5 Nuclear factor-kappaB pathway 
One of the most important signaling pathways responsible for regulating immune 
responses in vertebrates is the NF-κB pathway (Moynagh, 2005). NF-κB proteins are well 
characterized in many animal phyla, including chordates (Gilmore & Wolenski, 2012). 
Homologues have been recently identified in molluscan species, including the Pacific oyster 
(Crassostrea gigas), the bobtail squid (Euprymna scolopes) and a species of abalone (Haliotis 
diversicolor supertexta) (Montagnani et al. 2004; Goodson et al. 2005; Jiang & Wu, 2007). 
However, little is known about molluscan NF-κB homologues regarding their functional role as 
transcription factors. The functional studies that have been carried out have mostly entailed 
expression analyses of the transcription factors themselves following exposure to pathogens 
(Adema et al. 2009; Zhang & Coultas, 2011). 
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In general, NF-κB proteins either form homo- or heterodimers that vary in their relative 
affinities to a particular DNA binding site (Chen & Ghosh, 1999). NF-κB typically functions as a 
heterodimer composed of p50 and p65 proteins. Interestingly, the two genes that were recently 
identified by Zhang and Coultas (2011) in B. glabrata show most similarly to p50 and p65 
proteins in other species. All NF-κB proteins have a highly conserved amino-terminal domain 
called the Rel homology domain (RHD) (Fig. 4-5). The RHD is approximately 300 amino acids 
in length and contains regions that are involved in dimerization, sequence-specific DNA binding, 
inhibitory IκB binding, and nuclear localization (Chen & Ghosh, 1999). The carboxyl-terminus 
of the RHD has a nuclear localization sequence (NLS), which is responsible for “tagging” a 
protein for nuclear translocation (Liang et al. 2004; Franzenburg, 2012).  
 
Figure 4. BgNF-κB p65 protein indicating the Rel homology domain. This domain contains a nuclear 
localization sequence (NLS) and assists with highly specific DNA-protein interactions. 
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Figure 5. BgNF-κB p65 protein sequence. The portion highlighted in red represents the Rel homology 
domain (RHD). Image adapted from J. Humphries (2015). 
 
The NF-κB signaling pathway can be activated by a variety of transmembrane receptors, 
e.g. TLRs, that can bind to shared components on the surface of pathogens (Fig. 6; Franzenburg 
et al. 2012). In unstimulated cells, NF-κB is held within the cytoplasm in an inactive form by a 
family of inhibitory kappa-binding (IκB) proteins, such as IκBα and IκBβ (Jiang & Wu, 2007). 
These proteins bind to NF-κB via multiple ankyrin-repeats, which mask the NLS to inactivate 
NF-κB (Moynagh, 2005; Jiang & Wu, 2007). Upon stimulation, IκB kinases (IKKs) signal IκB 
to phosphorylate, which is immediately followed by the binding of a ligase complex that adds 
ubiquitin to IκB, targeting it for degradation by the 26S proteasome (Jiang & Wu, 2007; 
Franzenburg et al. 2012). This process exposes the NLS, thereby freeing the NF-κB and allowing 
it to translocate to the nucleus. Inside the nucleus, NF-κB binds to highly specific DNA 
sequences called response elements to activate target genes (e.g., cytokines, adhesion molecules, 
acute phase proteins) for gene transcription (Moynagh, 2005). 
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Figure 6. Nuclear factor-kappaB pathway. 1) NF-κB is activated by proinflammatory cytokines (e.g., tumor 
necrosis factor-α) or pathogen-associated molecular patterns (e.g., lipopolysaccharide). 2) IκB kinases (IKKs) 
signal IκB to phosphorylate. 3) The IκB inhibitor is ubiquitinated, leading to degradation by the 26S 
proteasome. 4) NF-κB dimers (p50 and p65) then undergo nuclear translocation. 5) Once inside the nucleus, 
transcription is initiated and target genes are activated. 
 
 NF-κB can be activated by TLRs, which are type-1 transmembrane receptors that can 
recognize components common to multiple infectious agents, e.g., peptidoglycan (PGN) (Fig. 7; 
Zhang & Ghosh, 2001). To illustrate, TLRs bind to their respective ligand, e.g. PGN, to initiate a 
signaling pathway that can ultimately activate NF-κB. The TLR–NF-κB pathway is thought to be 
an ancient host defense mechanism, as members of this pathway have been identified in 
cnidarians and sponges (Putnam et al. 2007; Gauthier & Degnan, 2008). Additionally, 
components of this pathway have also been identified in several molluscan species (Xiong et al. 
2008; He et al. 2013; Toubiana et al. 2013; Valenzuela-Munoz, 2014). 
 TLR-ligand binding interactions can trigger a cascade of events that lead to NF-κB 
activation. A cascade can be considered as “a series of events in which one event triggers the 
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next in a linear fashion” (Hinkle & Bowman, 2003). Intracellular signaling is initiated by 
Toll/interleukin-1 receptor (TIR) domain containing cytoplasmic adaptor proteins, such as 
myeloid differentiation factor 88 (MyD88) (Kawai & Akira, 2006). Following MyD88 
activation, a number of other downstream signaling proteins are activated, such as interleukin-1 
receptor-associated kinase (IRAK), tumor necrosis factor receptor-associated factor (TRAF), 
transforming growth factor β-associated kinase (TAK1), and IκB kinase (IKK) (Zhang & Ghosh, 
2001; Cornet et al. 2015).The activation of these downstream components ultimately leads to the 
nuclear translocation of NF-κB proteins and initiation of gene transcription (Franzenburg et al. 
2012; Cornet et al. 2015).  
 
Figure 7. Toll-like receptor mediated nuclear factor-kappaB pathway. 1) The TLR binds to a pathogen-
associated molecular pattern (PAMP), such as peptidoglycan (PGN). 2) Intracellular signaling is initiated by 
adaptor proteins, e.g. myeloid differentiation factor 88 (MyD88). 3) MyD88 associates with the cytoplasmic 
portion of TLR and recruits a downstream interleukin-1 receptor-associated kinase (IRAK) to the receptor 
complex. 4) IRAK becomes phosphorylated and dissociates from the complex to recruit tumor necrosis factor 
receptor-associated factor (TRAF). 5) This allows downstream kinases, e.g. TAK1, to stimulate an IκB kinase 
(IKK). 6) After IKK is activated, NF-κB can translocate to the nucleus to initiate gene transcription. 
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1.6 Nuclear factor-kappaB binding site prediction 
 One way to study which genes are regulated by NF-κB transcription factors is to identify 
NF-κB binding sites, commonly referred to as kappa-binding (κB) sites (Fig. 8). These 
transcription factor binding sites, which are short genomic sequences (around 5-15 bp), can be 
found upstream, downstream, or within introns of the genes that they regulate (Lodish et al. 
2000). In addition, they can be close or far in proximity to the beginning of the open reading 
frame of the target gene, which is the DNA sequence that codes for a protein. If the putative 
binding site is within the vicinity of the gene, then it is thought that this sequence might be able 
to bind to a protein of interest to assist with gene regulation. Transcription factor binding sites 
can be predicted by using databases, such as the Transcription Factor database (TRANSFAC) 
and the Open Regulatory Annotation database (ORegAnno) (Wingender et al. 2000; 
Montgomery et al. 2005). More recently, Lee and Huang (2014) developed a new transcription 
factor binding site search algorithm called Length-Aware Site Alignment Guided by Nucleotide 
Association 2.0 (LASAGNA 2.0), which is a specific algorithm based on the idea that binding 
sites share a common core with a few varying nucleotides on one or both ends of the sequence 
(Lee & Huang, 2014). The programs mentioned previously can find sequences that resemble 
other known binding sites, but LASAGNA 2.0 has been shown to be a faster and more accurate 
tool for predicting transcript expression (Lee & Huang, 2014). 
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Figure 8. A nuclear factor-kappaB transcription factor interacting with a kappa-binding site to regulate 
gene expression. Image adapted and edited from www.igem.org. 
 
 It is especially important to perform functional assays because we have not yet confirmed 
if these predicted binding sites, which resemble known vertebrate sequences, may function 
similarly within invertebrates, such as B. glabrata. Transcription factor binding sites can be 
functionally characterized using a variety of approaches, including a common technique called 
an electrophoretic mobility shift assay (EMSA) (Fig. 9; Geertz & Maerkl, 2010). EMSAs are 
used to determine if transcription factor proteins can interact with and bind to nucleic acids. In 
this assay, various combinations of protein and DNA are incubated and then subjected to gel 
electrophoresis on a non-denaturing polyacrylamide gel (Hellman & Fried, 2007). DNA probes 
are labeled with radioisotopes, fluorophores, or biotin, which can then be detected via an array of 
imaging techniques (Rowe & O’Gara, 2016). This assay is based on the principle that a protein-
DNA complex is higher in molecular weight than the labeled DNA probe alone. That is, the 
protein-DNA complex will migrate down the gel much more slowly compared to a free probe, 
which generates a characteristic “mobility shift” to compare the location of a protein-DNA 
complex to DNA alone (Fig. 9; Rowe & O’Gara, 2016). This procedure can also be used to 
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examine the specificity of a protein-DNA interaction. Mutant probes can be designed to examine 
how the altered nucleotides may impact the binding affinity of the DNA probe to the 
recombinant protein (Hellman & Fried, 2007). We can also subject various mixtures of protein 
and DNA to competition assays. By adding a competing unlabeled DNA probe to the mixture, 
we can determine if the protein of interest binds to the target probe with greater affinity than the 
competing probe (Rowe & O’Gara, 2016).  
 
Figure 9. Overview of the electrophoretic mobility shift assay. The assay tests the functionality of a 
transcription factor by examining protein-DNA binding interactions. Lane 1 represents free DNA. Lane 2 
shows a “shift”, which indicates that the protein (transcription factor) is interacting with the DNA (binding 
site). Lane 3 examines the specificity of the interaction; upon altering the DNA sequence, no shift is observed 
because protein binding is inhibited. Competition assays can be performed. Lane 4 indicates a lack of DNA-
protein binding when adding a higher fold excess of unlabeled wild-type probe. Lane 5 reveals that binding 
can still occur when adding the same fold excess of an unlabeled mutant probe.  
 EMSAs are sensitive to a variety of factors (e.g., pH, buffer composition, salinity) and 
therefore require much optimization (Hellman & Fried 2007). In addition, protein-DNA 
complexes are not at chemical equilibrium when run down a gel, so rapid dissociation during 
electrophoresis could prevent detection of the complex (Rowe & O’Gara, 2016). Despite these 
issues, the assay presents several advantages, including the use of small volumes (20 µL or less) 
as well as the ability to use a wide range of DNA probe lengths (Hellman & Fried, 2007). 
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1.7 Identification of nuclear factor-kappaB gene targets 
 More generally, EMSAs have been used to examine in vitro DNA-protein interactions. 
To date, DNA-NF-κB binding has been examined in just two molluscan species, C. gigas and B. 
glabrata (Jiang & Wu, 2007; Humphries & Harter, 2015). Jiang and Wu (2007) showed that the 
recombinant Ab-Rel RHD from H. diversicolor supertexta can bind to a vertebrate κB site. 
Likewise, Humphries and Harter (2015) reported that the B. glabrata RHD could bind to a 
vertebrate consensus probe. Humphries and Harter (2015) were also the first to use EMSAs to 
functionally characterize molluscan κB sites by showing specific binding between a molluscan 
RHD and a molluscan putative binding site. The molluscan κB sites that were characterized in 
their study were reported upstream of two immune genes (p38 mitogen-activating protein kinase 
(MAPK) and IκBα) in B. glabrata (Humphries & Harter, 2015). Previous studies suggest that 
p38 MAPK plays a role in generating immune responses within B. glabrata. More specifically, 
p38 MAPK has been shown to participate in in vitro H2O2 production, which is an anti-
schistosome defense mechanism used by resistant strains of B. glabrata (Goodall et al. 2004; 
Yoshino & Humphries et al. 2008). Overall, Humphries and Harter (2015) showed that the B. 
glabrata RHD could interact with the κB sites discovered upstream of both Bgp38 MAPK and 
BgIκBα, which implies that the expression of both of these genes may be regulated by BgNF-κB. 
The findings in this study led us to wonder if BgNF-κB may regulate other immune genes, such 
as components of the TLR pathway. Previous studies suggest that NF-κB regulates TLRs in 
vertebrate models, so it was of great interest to determine if a B. glabrata NF-κB p65 protein 
might be able to function similarly (Takeshita et al. 2004; Johnson & Tapping, 2007).  
 The aim of this research project was to determine if NF-κB can regulate other immune 
genes in the TLR–NF-κB pathway within B. glabrata. If NF-κB does indeed regulate such 
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immune genes, then putative κB sites should be found within the vicinity of the protein coding 
region of interest. In order to address this question, bioinformatics analyses were used to identify 
putative κB sites near various immune genes. Following, EMSAs were used to functionally 
assess the predicted κB sites. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18 
 
MATERIALS AND METHODS 
2.1 Identification of putative kappa-binding sites 
Prediction of putative kappa-binding sites 
 In order to examine whether NF-κB might regulate gene expression of immune genes in 
the TLR pathway, we searched for putative kappa-binding (κB) sites within the vicinity of the 
genes of interest. The genomic DNA sequences upstream of protein coding regions for 20 genes 
representing the TLR mediated NF-κB pathway were acquired from VectorBase 
(http://www.vectorbase.com), which houses the genome for B. glabrata. The amino acid 
sequence for each gene was aligned to sequences within the snail genome using the Basic Local 
Alignment Search Tool (BLAST) (Altschul et al. 1990). BLAST allows one to search nucleotide 
and protein databases for sequences that are similar to the sequence of interest. The program, 
tblastn (peptide vs. translated nucleotide), was used to align the input protein sequence to 
nucleotides within the snail genome that were translated to hypothetical amino acid sequences. 
The section of the genomic DNA (scaffold) showing the highest level of identity to the input 
sequence was selected for further analysis. The upstream region (2000 bp) for each gene was 
then retrieved and exported as a Fast Alignment (FASTA) sequence. 
 The upstream region was then inserted into the search engine, Length-Aware Site 
Alignment Guided by Nucleotide Association 2.0 (LASAGNA 2.0; http://biogrid-
lasagna.engr.uconn.edu/lasagna_search/), which is an algorithm that scans DNA sequences of 
interest for potential transcription factor binding sites (Lee & Huang, 2013). Certain 
Transcription Factor database (TRANSFAC) nucleotide matrices were selected to search for 
putative binding sites within the upstream regions of each gene (Wingender et al. 2000). Five 
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NF-κB matrices were used to find potential κB sites (NF-κB p65 (M00052), NF-κB p50 
(M00051), NF-κB (M00208), NF-κB (M00194) and NF-κB (M00054)). Statistically significant 
results were accepted at P<0.001. 
 In addition to searching upstream of the protein coding region, we also looked within 
introns of several members of the TLR mediated NF-κB pathway. Methods for analyses were the 
same as above except BLAST was used to find the genomic DNA sequence of the protein coding 
region for each respective gene. These genomic sequences contained exons that code for the 
protein, interspersed with introns that do not code for the protein, but can play a regulatory role 
(e.g., by containing transcription factor binding sites). The sequence analysis software package 
program, Vector NTI® (Life Technologies, Grand Island, NY, USA), was then used to locate and 
acquire all the introns within each gene of interest.  
Selection of putative kappa-binding sites for electrophoretic mobility shift assays 
 Members of the TLR-mediated NF-κB pathway were selected for functional analyses 
based on their fundamental role in the pathway. When looking for putative binding sites both 
upstream and within introns, some sequences contained many successful hits. The criteria for 
selection of predicted binding sites is as follows: (1) the sequence of interest was required to 
appear on the sense strand; (2) overlapping sequences generated from a single matrix were 
discarded and the hit with the best score was selected; and (3) hits for more than one matrix 
localized in the same site were discarded to avoid redundancy. If these criteria were met, the 
sequence that corresponded to the highest ranked matrix was considered as a positive hit. Out of 
the five matrices utilized in this study, putative binding sites that were predicted based on 
similarity to the NF-κB p65 matrix (M00052) were ranked the highest because the B. glabrata 
RHD used in EMSAs represents the RHD from BgNF-κB p65 (NCBI Accession No. 
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ACZ25559.1). NF-κB p65 proteins often function as a heterodimer with NF-κB p50 proteins so 
additional matrices were selected because they represent binding sites recognized by vertebrate 
NF-κB p50 proteins. 
 Nine predicted κB sites were selected for further functional analyses using EMSAs. 
These sequences were selected based on their score, i.e. the predicted site with the highest score, 
lowest P-value, and lowest E-value (for any one gene). Oligonucleotide probes containing the 
predicted binding site were required to see if they interacted with the RHD protein via EMSAs. 
Wild-type oligonucleotide probes (30 bp in length) were designed and comprised of a 10 bp 
putative kappa-binding site with an additional 10 bp on both the 5’ and 3’ flanking regions. In 
order to generate mutant probes, the first half-site of the kappa-binding site was altered to        
5’-CTCAA-3’. This five bp sequence was selected because it was shown to inhibit binding in a 
previous study between the BgRHD and its associated B. glabrata κB site (Humphries & Harter, 
2015). Both forward and reverse strands for these probes were synthesized by the Midland 
Certified Reagent Company (Midland, Texas, USA). Following synthesis, probes were purified 
using high performance liquid chromatography (HPLC). 
2.2 Biotin labeling 
 The oligonucleotide probes were labeled with biotin, which is a stable, high-affinity 
protein, allowing the probe to be visualized upon later detection. Specifically, the probes were 
labeled with 1,3 biotinylated ribonucleotides onto the 3’-OH end of the DNA strands, according 
to the manufacturer’s instructions (Biotin 3’ End DNA Labeling Kit, Pierce TM, Rockford, IL, 
USA). Biotin labeling reactions (25 µL) were prepared by adding and mixing the following 
components: 12.5 µL Milli Q water, 5 µL 5 X TdT reaction buffer, 2.5 µL unlabeled 
oligonucleotide (1 µM), 2.5 µL biotin-11-UTP (5 µM), and 2.5 µL diluted terminal 
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deoxynucleotidyl transferase (TdT) (1.5 U/µL). The TdT enzyme catalyzed non-template-direct 
deoxynucleotide incorporation onto the 3’-OH end of each strand for each probe. Reactions were 
incubated at 37ºC for 30 min. Following incubation, 2.5 µL of 0.2 M ethylenediaminetetraacetic 
acid (EDTA) were added to each sample in order to stop the reaction. Fifty microliters of 
chloroform:isoamyl alcohol (24:1) were added to each reaction to extract the TdT. The mixture 
was then vortexed briefly and centrifuged at room temperature (2 min at 13.2 revolutions per min 
(RPM)) (Eppendorf 5415R, Hamburg, Germany) to separate the phases. Forward and reverse 
probes were incubated for 1 hr at room temperature. For unlabeled probes, equal parts of forward 
and reverse probes were combined in one tube and were given 1 hr to anneal at room 
temperature. All samples were stored at -20ºC for future use. 
2.3 Preparation of Samples 
 The sequence representing the RHD from the B. glabrata NF-κB p65 (amino acids 83-
392; NCBI Accession No. ACZ25559.1) was inserted into a vector (pET-32a). The recombinant 
BgRHD was then expressed in Escherichia coli by the biotechnology company, GenScript 
(Piscataway, NJ, USA). Double stranded biotin-labeled probes (20 fmol) were incubated with 0.3 
mg/mL BgRHD, 0.5 μg/μL Poly I:C (ThermoScientific, Waltham, MA, USA), in addition to 2 
μL 50% glycerol, and 2 μL 10 X binding buffer (10 mM Tris, 50 mM potassium chloride (KCl), 
1 mM Dithiothreitol (DTT), pH 9.0). Samples were then incubated at room temperature for 30 
min. Competition assays were also completed to examine the specificity of the interaction 
between the BgRHD and the labeled wild-type oligonucleotide probes. These assays were used 
to determine if the BgRHD could still bind to the labeled wild-type probe when in the presence 
of an excess unlabeled mutant probe. Additionally, the competition assays were performed to 
examine if the BgRHD may bind with less affinity to the labeled wild-type probe when in the 
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presence of an excess unlabeled wild-type probe. Both unlabeled wild-type and unlabeled mutant 
probes were added at a 500-fold excess (4 pmol) for competition assays. 
2.4 Electrophoretic mobility shift assay 
Gel electrophoresis 
 A non-denaturing, 6% polyacrylamide gel in 0.25 X Tris borate EDTA buffer (EDTA pH 
8.0; all adjusted to pH 9.0) was prepared and degassed for 15 min before adding 
tetramethylethylenediamine (TEMED) and ammonium persulfate (APS). The gel was then 
poured and was allowed to polymerize using the Bio-Rad Mini-PROTEAN® tetra cell hand 
casting module (Berkeley, CA). Acrylamide gels were given 2 hr to polymerize prior to use. 
Gels, which were wrapped in damp paper towels and plastic wrap, were stored at 4ºC until used 
within 48 hr of polymerization. 
 Gel electrophoresis was performed using a Bio-Rad MINI-PROTEAN® tetra vertical 
electrophoresis cell system (Berkeley, CA). After assembling the apparatus, each well was 
flushed out twice with 200 µL 0.25 X TBE buffer. The acrylamide gel was pre-run at 100 V in 
0.25 X TBE buffer for 30 min to remove excess traces of APS. Afterwards, the wells were rinsed 
again twice with 0.25 X TBE buffer. Samples (20 µL) were then loaded into each well. Note that 
an aliquot (2.5 µL) of loading dye (ThermoScientific, Waltham, MA, USA) was added to the 
lane containing solely the labeled oligonucleotide probe in order to track the samples as they ran 
down the gel. The voltage was then reduced to 70 V and samples were allowed to migrate down 
the gel for 20-30 min. 
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Transferring the gel 
  A Mini Trans-Blot® tetra cell tank blotting system (Bio-Rad, Berkeley, CA) was used to 
transfer the DNA and protein contents from the gel onto a nylon membrane (type B positive, 
Fluka Analytical, St. Louis, MO, USA). The nylon membrane was presoaked in 0.25 X TBE 
buffer for 15 min prior to use. The membrane sandwich was prepared according to the 
manufacturer’s instructions with sponges, filter paper (Extra Thick Blot Filter Paper, Bio-Rad, 
Berkeley, CA), the polyacrylamide gel, and the pre-soaked nylon membrane. The gel was then 
given 1-2 hr to transfer at 33 V in 0.25 X TBE and an ice pack was added during the transfer to 
prevent overheating of the gel. Afterwards, the free DNA, free protein, and protein-DNA 
complexes were all cross-linked onto the membrane by using a UVP ultraviolet crosslinker   
(CL-1000, Upland, CA). 
Chemiluminescent detection 
 Chemiluminescence was used to detect the presence of biotin-labeled probes on the nylon 
membrane, according to the manufacturer’s instructions (Chemiluminescent Nucleic Acid 
Detection Module, ThermoScientific, Waltham, MA, USA). The washing buffer and blocking 
buffer from the detection module were incubated in a water bath at 40ºC for approximately 10 
min to dissolve all particulate matter. The transferred nylon membrane was then soaked in 
blocking buffer for 15 min. The membrane was incubated for an additional 15 min in blocking 
buffer that contained stabilized, streptavidin-horseradish peroxidase (SA-HRP) conjugate (1:300 
dilution). This peroxide-conjugated streptavidin binding protein interacts very strongly with the 
biotin-labeled probes and provides signal amplification during visualization. The nylon 
membrane was then rinsed several times in 1 X wash buffer (4 x 5 min). Afterwards, the 
membrane was incubated in equilibration buffer for 5 min. Immediately following this step, the 
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membrane was developed with compatible enhanced chemiluminescence (ECL) reagents 
(Chemiluminescent Nucleic Acid Detection Module, ThermoScientific, Waltham, MA, USA). 
Equal parts (0.5 mL each) of stable peroxide solution and luminol enhancer were applied onto a 
Kodak imager (Image Station 4000 mm Pro, Rochester, NY) and the membrane was then placed 
protein side down onto the ECL solution. The membrane was exposed for 5 min. Images were 
collected and stored as tagged image file format (TIFF) files on the computer. For each predicted 
κB site that was tested, EMSAs were repeated for a total of three replicates. 
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RESULTS 
3.1 Identification of putative kappa-binding sites associated with the Toll-like 
receptor mediated nuclear factor-kappaB pathway in B. glabrata 
Upstream analysis 
 Approximately 2000 bp of genomic DNA upstream of the protein coding region for 20 
members of the TLR pathway were surveyed for potential κB sites (Table 1). Sequences 
upstream of 16 of these genes (BgTLR1, BgTLR2, BgTLR4, BgMyD88, BgSARM, BgIRAK, 
BgTAB, BgTAK, BgIKKα, BgIKKγ, BgUev1a, BgIκBβ, BgNF-κB p65, BgNF-κB p105, 
BgLITAF, and BgAP-1) contained putative κB sites. Often, more than one putative binding site 
was predicted upstream of each of these genes. Typically, there were between one and four 
reported hits for the 16 upstream regions described above. Out of the 20 DNA sequences 
subjected to analysis, only four (BgTLR3, BgTRAF, BgIKKγ, and BgIRF) did not contain 
putative κB sites. 
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Table 2. Identification of putative kappa-binding sites within 2000 bp upstream of 16 members of the 
TLR–NF-κB pathway in B. glabrata. The genomic DNA upstream of the protein coding region was 
submitted to the transcription binding site search engine, Length-Aware Site Alignment Guided by Nucleotide 
Association 2.0 (LASAGNA 2.0). Data highlighted in blue represent sequences that were selected for further 
analyses and their respective genes. Position number indicates number of base pairs upstream of the A 
nucleotide of the start codon (ATG). 
 
 
 In order to test our methodology, we surveyed the upstream region of two additional 
genes (BgIκBα and Bgp38 MAPK) that were previously analyzed by Humphries and Harter 
(2015). Four hits were displayed for each gene (Table 6). Sequences exhibiting the highest scores 
from our bioinformatics analyses were identical to the putative κB sites that were selected for 
functional analyses by Humphries and Harter (2015). 
Control Region Sequence Position Number of κB sites 
BgTLR1 agtgattccc -274 1 
BgTLR2 ggaagtttc 
gggaagtttc 
-25 
-1928 
2 
BgTLR3 - - None 
BgTLR4 ggaatcttcc -1829 1 
BgTLR5 gggattttac -1466 1 
BgMyD88 ggacgttctt -1639 1 
BgSARM ggaattcact 
gggaatgtct 
-665 
-512 
2 
BgTRAF - - None 
BgIRAK ggtattttac -175 1 
BgTAB ggaaactcca -457 1 
BgTAK - - None 
BgIKKα ggggatctca -862 1 
BgIKKγ tgtactttcc -1464 1 
BgUev1a ggaacttacc -1157 1 
BgIκBβ tggaaattcc 
ggggaatccc 
tggaacttcc 
tcgaatttcc 
-159 
-290 
-1742 
-1774 
4 
BgNF-κB p105 gggaaagtcc -1257 1 
BgNF-κB p65 ggggattttc 
gggattttct 
-820 2 
BgLITAF ggtttttcc 
gggtttctcc 
-250 
-267 
2 
BgIRF - - None 
BgAP-1 gggaaatcct -356 1 
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Intron analysis 
 We also surveyed the introns for potential putative κB sites from the 20 members of the 
TLR–NF-κB pathway (Table 3). Twelve genes (BgTLR1, BgMyD88, BgSARM, BgTRAF, 
BgIRAK, BgTAK, BgTAB, BgUev1a, BgIKKγ, BgNF-κB p105, BgNF-κB p65 and BgLITAF) 
contained introns for analyses. There were between one and eight predicted putative κB sites for 
these genes. In contrast, no putative binding sites were identified within the introns of BgIκBβ. It 
should be noted that the genes for BgTLR2, BgTLR3, BgTLR4 and BgAP-1 did not contain 
introns so they were not included in this particular analysis. Additionally, it was not possible to 
analyze the introns within BgIKKα because the gene was split between two scaffolds in the 
current draft of the genome. 
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Table 3. Identification of putative kappa-binding sites within introns of the genes coding for 12 members 
of the TLR–NF-κB pathway. The genomic DNA within introns of the protein coding region was submitted to 
the transcription factor binding site search engine, Length-Aware Site Alignment Guided by Nucleotide 
Association 2.0 (LASAGNA 2.0). Position number indicates number of base pairs downstream of the A 
nucleotide of the start codon (ATG). 
Control Region Sequence Position Number of κB sites 
BgTLR1 gggacataac 
gggaagtttc 
+1,046 
+273 
2 
BgMyD88 cggagtttcc 
gggaaactcc 
ggaaaattac 
ggaactttac 
ttggaaacttctga 
tggaatcccc 
ggacttcaca 
+3,004 
+2,438 
+2,881 
+2,422 
+3,714 
+5,716 
+7,608 
7 
BgSARM tggagattcc 
aaggcacattcctc 
tttgaaatttctct 
aatggaattactat 
gggaataacc 
gggaagttac 
attgaactttacta 
+6,496 
+4,472 
+10,659 
+11,642 
+14,462 
+17,830 
+20,316 
7 
BgTRAF tggggattttc 
ttgaatttcc 
ggggatttct 
gggaattcac 
gggaaattat 
gggactctgct 
aatgaaatttacta 
gatggaacttctcc 
+11,633 
+23,355 
+23,383 
+16,030 
+20,510 
+17,758 
+16,376 
+22,828 
8 
BgIRAK ggatactcca 
ggagatctcc 
+10,219 
+10,821 
2 
BgTAB atggaactttcttt +585 1 
BgTAK tgtggacataccac 
aaggggacattatat 
gggaaaatcc 
+3,352 
+5,274 
+14,373 
3  
BgIKKγ tgtactttcc 
tggaattcc 
+1,704 
+6,120 
2 
BgUev1a tgaaaattcc 
ggacactcca 
aatggatttatat 
cgggtttccc 
agtggacttactga 
+5,010 
+1,666 
+549 
+6,188 
+6,297 
5 
BgIκBβ - - None 
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BgNF-κB  p105 tttggatgttcctt 
agagaaatttactt 
tgaaaattcc 
ttgaattccc 
ggaattccc 
gggacagccc 
gggatttttaa 
+289 
+2,148 
+5,912 
+11,603 
+17,037 
+18,145 
+18,524 
7 
BgNF-κB p65 ggggattttc 
tgggaaattctca 
gtgattttcaa 
ttgtgaccttccat 
+1,340 
+3,093 
+8,734 
+12,722 
4 
BgLITAF ggggttttct 
taggtactttcttc 
+2,449 
+3,919 
2 
  
Selection of genes for functional analyses using electrophoretic mobility shift assays 
 Nine genes (BgTLR1, BgTLR2, BgMyD88, BgIRAK, BgIKKα, BgIκBβ, BgNF-κB p105, 
BgNF-κB p65 and BgLITAF) were selected for functional analyses. When more than one κB site 
was predicted upstream of the coding region for a gene of interest, the predicted site with the 
highest score and lowest respective E-value and P-value was selected for EMSA assays (Table 
4). Putative κB sites were predicted upstream of the protein coding regions for BgTLR1                 
(5’-AGTGATTCCC-3’) and BgTLR2 (5’-GGGAAGTTTC-3’) at positions -274 bp and -25 bp 
from the start codon, respectively. Additionally, putative κB sites were reported upstream of the 
protein coding regions for BgMyD88 (5’-GGACGTTCTT-3’), and BgIRAK                            
(5’-GGTATTTTAC-3’) at -1639 bp and -175 bp from the start codon, respectively. Putative κB 
sites were also shown for BgIKKα (5’-GGGGATCTCA-3’), BgIκBβ (5’-TGGAAATTCC-3’), 
BgNF-κB p105 (5’-GGGGATTTTC-3’), and BgNF-κB p65 (5’-GGGAAAGTCC-3’). The 
putative κB sites were predicted upstream of the coding region for these genes, -862 bp, -159 bp, 
-1257 bp, and -820 bp from the start codon, respectively. Additionally, a LITAF homologue was 
selected for functional assays to determine if BgNF-κB can potentially play a regulatory role in 
the expression of another transcription factor. The putative binding site for BgLITAF               
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(5’-GGGTTTTTCC-3’) was predicted -250 bp upstream the start codon. The 10 bp sequences for 
all of the genes listed above were used to create oligonucleotide probes (Table 4). 
Table 4. Putative kappa-binding site predictions in B. glabrata. The predicted sequences were found using 
the transcription factor binding site search engine, Length-Aware Site Alignment Guided by Nucleotide 
Association 2.0 (LASAGNA 2.0). The position is indicative of how close binding site is from the first 
nucleotide (A) of the start codon (ATG). The score represents the sequence similarity of the predicted binding 
site to the respective matrix. The P-value is the probability that an event occurs by chance (P<0.05), whereas 
the E-value is the expected number of times a hit of the same or higher score is found in the promoter sequence 
by chance. 
Name Sequence Position Score P-value E-value 
BgTLR1 AGTGATTCCC -274 8.83 0.0006 1.31 
BgTLR2 GGCCATTCCC -25 8.09 0.001 2.09 
BgMyD88 GGACGTTCTT -1639 6.89 0.001 2.03 
BgIRAK GGTATTTTAC -175 9.91 0.0003 0.63 
BgIKKα GGGGATCTCA -862 7.25 0.0003 0.58 
BgIκBβ TGGAAATTCC -159 13.78 0 0 
BgNF-κB p105 GGGAAAGTCC -1257 9.11 0.0002 0.42 
BgNF-κB p65 GGGAACTTCC -820 10.96 0.0001 0.15 
BgLITAF GGGTTTTTCC -250 12.49 0.00008 0.149 
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Table 5. Oligonucleotide probes used in electrophoretic mobility shift assays. All probes (30 bp long) 
consisted of a central predicted κB site (in purple), in addition to both 5’ and 3’ flanking regions. Mutant 
probes were generated by changing the first half-site of the κB site to 5’-CTCAA-3’ (in red). Only the forward 
primer is displayed for both wild-type and mutant probes, but both forward and reverse strands were used in 
electrophoretic mobility shift assays. 
 
 
3.2 Electrophoretic mobility shift assays 
 EMSAs were performed to determine whether the BgRHD could recognize and bind to 
several putative κB sites that were identified upstream of the protein coding region for members 
of the TLR mediated NF-κB pathway. EMSA analyses confirmed that BgRHD could recognize 
Probe Nucleotide sequence 
BgTLR1 wild-type ttcttttacgagtgattccccaggcggcta 
BgTLR1 mutant ttcttttacgctcaattccccaggcggcta 
BgTLR2 wild-type tgtgcaactgggccattcccccatttatat 
BgTLR2 mutant tgtgcaactgctcaattcccccatttatat 
BgMyD88 wild-type tttcttccttggacgttcttcagtgccagc 
BgMyD88 mutant tttcttccttctcaattcttcagtgccagc 
BgIRAK wild-type atgtgtcattggtattttacattcataaaa 
BgIRAK mutant atgtgtcattctcaatttacattcataaaa 
BgIKKα wild-type tgccagccctggggatctcattatatgtct 
BgIKKα mutant tgccagccctctcaatctcattatatgtct 
Bg IκBβ wild-type tgttgtcgcatggaaattccaccgaaaaat 
BgIκBβ mutant tgttgtcgcactcaaattccaccgaaaaat 
BgNF-κB p105 wild-type accttaactagggaaagtccctacaatatt 
 
BgNF-κB p105 mutant accttaactactcaaagtccctacaatatt 
BgNF-κB p65 wild-type gggtccgggggggaacttcccccccccccc 
BgNF-κB p65 mutant gggtccggggctcaacttcccccccccccc 
BgLITAF wild-type tccagctcgtgggtttttccagcgtgtgaa 
BgLITAF mutant tccagctcgtctcaatttccagcgtgtgaa 
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and bind to six wild-type, biotin-labeled probes: BgTLR2, BgIRAK, BgIκBβ, BgNF-κB p105, 
BgNF-κB p65 and BgLITAF. In comparison, BgRHD binding was substantially reduced or 
inhibited when incubated with mutant, biotin-labeled probes. Competition assays were 
performed to determine if the interaction between the BgRHD and probe complex was specific. 
Binding between the BgRHD and wild type, biotin-labeled probes was decreased and in some 
occasions eliminated by the addition of a 500-fold excess of the equivalently unlabeled wild type 
probe. In contrast, binding between the BgRHD and labeled wild-type probe remained 
unchanged with the addition of a 500-fold excess of equivalently unlabeled mutant probe. This 
indicates that the interactions between both BgRHD and six wild-type probes are specific (Fig. 
10-15). 
 However, our findings vary from κB site to κB site in several ways. Binding interactions 
between the BgRHD and altered mutant probes (BgTLR2 and BgNF-κB p65) were not 
completely inhibited in some cases (Fig. 10 and 14). Additionally, the findings from our 
competition assays varied for some of the probes, where a reduction in specific binding was 
displayed between the BgRHD and the labeled wild-type probe (BgTLR2, BgIRAK, BgNF-κB 
p65, and BgLITAF) when incubated with a higher fold excess of unlabeled equivalent probe 
(Fig. 10-11, and 14-15, respectively; lane 4). In contrast, binding between the BgRHD and 
labeled wild-type probe for both BgIκBβ and BgNF-κB p105 was completely outcompeted when 
the specific DNA-protein complex was incubated with the addition of a higher fold excess of 
unlabeled wild-type probe (Fig. 12-13; lane 4).  
 EMSAs were also carried out for the putative κB sites identified upstream of BgTLR1, 
BgMyD88, and BgIKKα. When examining BgTLR1, BgRHD bound to the labeled wild-type 
probe but BgRHD also bound to the labeled mutant probe. This implies that the interaction 
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between the BgRHD and labeled wild-type was non-specific. In addition, BgRHD did not bind to 
labeled wild-type probes for either BgMyD88 or BgIKKα. 
 
Figure 10. Electrophoretic mobility shift assay for BgTLR2. The labeled wild-type probe is displayed in 
lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3, 
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and 
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5, 
respectively) (n = 3). 
 
 
Figure 11. Electrophoretic mobility shift assays for BgIRAK. The labeled wild-type probe is displayed in 
lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3, 
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and 
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5, 
respectively) (n = 3). 
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Figure 12. Electrophoretic mobility shift assays for BgIκBβ. The labeled wild-type probe is displayed in 
lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3, 
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and 
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5, 
respectively) (n = 3). 
 
 
Figure 13. Electrophoretic mobility shift assays for BgNF-κB p105. The labeled wild-type probe is 
displayed in lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe 
(lanes 2 and 3, respectively). Competition assays assess the specificity of the interaction by incubating the 
BgRHD and labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 
4 and 5, respectively) (n = 3). 
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Figure 14. Electrophoretic mobility shift assays for BgNF-κB p65. The labeled wild-type probe is displayed 
in lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3, 
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and 
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5, 
respectively) (n = 3). 
 
 
Figure 15. Electrophoretic mobility shift assays for BgLITAF. The labeled wild-type probe is displayed in 
lane 1. The BgRHD was incubated with either the labeled wild-type or labeled mutant probe (lanes 2 and 3, 
respectively). Competition assays assess the specificity of the interaction by incubating the BgRHD and 
labeled wild-type probe with either excess unlabeled wild-type or unlabeled mutant probes (lanes 4 and 5, 
respectively) (n = 3). 
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A)       B)    
Figure 16. Sequence alignment of B. glabrata kappa-binding sites predicted upstream of protein coding 
regions for members of the Toll-like receptor pathway. A) Alignment with sequences showing specific 
binding via EMSAs. Note the 5’ and 3’ conserved residues. B) Alignment with sequences that did not show 
binding to the BgRHD via EMSAs. Sequences (10 bp) were aligned using Vector NTI®. Note that BgIκBα and 
Bgp38 MAPK sequences were obtained from Humphries and Harter’s (2015) study. Yellow regions represent 
nucleotides that are identical across all aligned sequences, whereas blue regions show highly conserved with 
an identity level ranging between 50% and 99.9%. 
 
 
 
Figure 17. Multiple sequence alignment of B. glabrata oligonucleotide probe sequences predicted 
upstream of protein coding regions for members of the Toll-like receptor pathway. Sequences (30 bp) 
were aligned using Vector NTI®. Note that BgIκBα and Bgp38 MAPK sequences were taken from Humphries 
and Harter’s (2015) study. Yellow regions represent nucleotides that are identical across all aligned sequences. 
Blue regions show highly conserved with an identity level ranging between 50% and 99.9%. 
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Figure 18. B. glabrata kappa-binding site consensus sequence. All κB sites that bound successfully to the 
BgRHD were aligned using MEME-ChIP (http://meme-suite.org/tools/meme-chip). Note the 5’ and 3’ 
conserved residues. 
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DISCUSSION 
4.1 Characterization of κB sites upstream of genes involved in the TLR–NF-κB pathway 
 NF-κB related homologues have been identified in several molluscan species, although 
their functions and regulatory mechanisms are not well understood. One principal strategy for 
characterizing transcription factors is to identify and characterize DNA-binding sites that are 
compatible with the transcription factor of interest. The present study suggests that BgNF-κB can 
potentially regulate the expression of protein coding regions for a variety of members of the TLR 
pathway. Bioinformatics analyses revealed the presence of several putative NF-κB binding sites 
upstream of 16 genes of interest (Table 2). Additionally, several putative κB sites were predicted 
within introns of 12 genes of interest (Table 3). Out of the nine oligonucleotide probes that were 
subjected to EMSA analyses, six (BgTLR2, BgIRAK, BgIκBβ, BgNF-κB p105, BgNF-κB p65 
and BgLITAF) showed sequence specific binding interactions. In each of these cases, BgRHD 
recognized and bound to the labeled κB site of interest. The interactions between the NF-κB 
protein and respective κB sites were sequence specific, as very little to no binding was detected 
between the BgRHD and the probe that contained the altered 5’ half-site. Furthermore, 
competition assays demonstrated that the BgRHD and labeled wild-type probe still bound in the 
presence of a 500-fold excess amount of unlabeled mutant probe, further supporting the 
specificity of this interaction. Our successful EMSA analyses suggest that these genes may all be 
regulated in part by the B. glabrata NF-κB p65 transcription factor. These results expand upon 
those of Humphries and Harter (2015), in that six new κB sites have now been shown to bind to 
the same B. glabrata RHD. In response to our initial research question, our findings suggest that 
BgNF-κB may regulate selective components of the TLR–NF-κB immune response. 
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 Our findings add to our current understanding of overall NF-κB function. Until now, no 
other reports have shown the potential for NF-κB to play a role in regulating TLR expression in 
mollusks, so it is of particular interest that BgRHD bound specifically to the κB site that was 
discovered upstream of BgTLR2. Our findings can be compared to studies done in vertebrates 
(Musikacharoen et al. 2001; Tapping et al. 2007). For example, Musikacharoen et al. (2001) 
used EMSAs to show specific protein binding to a κB site (5’-GGGAACTTCC-3’) that was 
upstream of a mouse TLR. Furthermore, when comparing the mouse κB site with our snail κB 
site reported upstream of BgTLR2, it was seen that they shared an 80% identity in sequence. The 
fact that studies have shown the potential for NF-κB regulation of TLR expression in vertebrates 
supports our hypothesis that NF-κB may regulate TLR expression in B. glabrata. 
 In addition to surveying upstream regions of TLRs for potential binding sites, we also 
used bioinformatics to search for putative κB sites upstream of several kinases that are activated 
downstream of TLRs. Three genes (BgIRAK, BgIKKα and BgIKKγ) showed potential κB sites 
upstream of the start codon. In the present study, the presence of specific binding between the 
BgRHD and the κB upstream of BgIRAK implies that BgNF-κB might be able to regulate 
BgIRAK expression. NF-κB regulation of IRAK has not been shown previously in an 
invertebrate species, however Cui et al. (2010) reported a putative NF-κB binding site             
(5’-GGGACGCTGG-3’) -111 bp upstream of the transcriptional start site of the human IRAK-2 
gene of stressed human astroglial cells. Although functional assays were not directly performed 
on the predicted κB site, other experiments showed that NF-κB mediated transcriptional control 
occurred between -119 and +12 bp of the IRAK-2 promoter (Cui et al. 2010). This region 
encompasses the predicted κB site, which suggests that the human IRAK-2 κB site might be 
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under regulatory control by NF-κB. Our EMSA data are the first to suggest that IRAK 
expression may be regulated by NF-κB in mollusks. 
 Highly specific binding observed between BgRHD and the putative κB site reported 
upstream of IκBβ is similar to the interaction reported in Humphries and Harter’s (2015) study, 
where the same B. glabrata RHD also bound to a κB site discovered upstream of IκBα. Our 
EMSA data demonstrate that the β-subunit can function in a similar manner to that of IκBα. 
More broadly, these results imply that BgNF-κB might be able to self-regulate by promoting the 
transcription of its inhibitory protein, BgIκBβ, in a negative feedback loop. Additionally, NF-κB 
regulation of IκBs has also been seen in other studies, which may suggest that this negative 
feedback loop can be conserved among other species (De Martin et al. 1992; Brown et al. 1993; 
Sun et al. 1993; Thompson et al. 1995). 
 Until now, mostly RT-PCR studies have been utilized to examine NF-κB proteins in 
mollusks (Adema et al. 2009; Zhang & Coultas, 2011). In vertebrates, p105 is a precursor 
protein that can undergo co-translational processing by the 26S proteasome to generate p50 
(Moorthy et al. 2006). The p105 protein has been shown to function as both an NF-κB precursor 
as well as an IκB protein (Wan et al. 2009). It is of great interest that the κB site reported 
upstream of BgNF-κB p105 showed specific binding with the BgRHD, as this implies that 
BgNF-κB may self-regulate by promoting the transcription of p105. Alternatively, perhaps p105 
could function as a heterodimer with p65 if p105 can be cleaved to p50, which has been observed 
in other species (Moorthy et al. 2006). Additionally, our EMSA data suggest specific binding 
between the BgRHD and the κB site upstream of BgNF-κB p65. Interestingly, the 5’                 
(5’-GGGTCCGGGG-3’) and 3’ (5’-CCCCCCCCCC 3’) regions of the oligonucleotide probe 
were very G rich and C rich, respectively. These regions may be contributing to the smearing, 
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which is seen in Fig. 14. Although we do not know the exact mechanism by which this could be 
occurring, perhaps the flanking regions may be folding over one another to create hairpins, 
which would interfere with the proper annealing of the forward and reverse strands. Ultimately, 
our findings suggest that BgNF-κB can regulate its own expression through an auto-regulatory 
feedback loop (Scott et al. 1993).  
 In general, the characterization of NF-κB binding sites suggests that NF-κB may be 
regulating the expression of members of the TLR pathway. However, we do not expect NF-κB to 
be the only transcription factor regulating immune genes in B. glabrata. Homologues of 
additional transcription factors, e.g. STAT, STAT2, and CREB, have been identified in B. 
glabrata (Zhang & Coultas, 2011). In other species, these transcription factors have also been 
shown to regulate immune responses (Wang et al. 2003; Wen et al. 2010). 
 In the present study, we searched for putative κB sites within the upstream region of three 
different transcription factors (BgAP-1, BgIRF, and BgLITAF) that regulate gene expression for 
various signaling proteins. We also expanded our search to look for putative κB sites within 
introns of the coding regions for these genes. Based on our bioinformatics results, it is not 
expected that the predicted NF-κB binding site for BgAP-1 might interact specifically with 
BgRHD because the low associated score (6.88) (Table 4). In comparison, no predicted binding 
sites were reported upstream of BgIRF. This contrasts with findings done by Lu et al. (2002), 
who characterized a functioning κB site next to the TATA box for the human IRF7 gene. 
However, EMSA analyses show that BgRHD bound to a κB site predicted upstream of 
BgLITAF, which suggests that NF-κB may be able to regulate LITAF expression in B. glabrata. 
Likewise, putative NF-κB binding sites have been reported upstream of LITAF homologues in 
C. gigas as well as the Whiteleg shrimp (Litopenaeus vannamei) (Park et al. 2008; Wang et al. 
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2012). Interestingly, our functional κB site shares 60% identity with the predicted κB site                   
(5’-GGGCATCGCA-3’) reported within the promoter region of the LITAF gene in L. vannamei 
(Wang et al. 2012). 
 Despite these overall findings, no sequence specific binding interactions were reported 
between BgRHD and three other putative κB sites reported upstream of BgTLR1, BgMyD88, and 
BgIKKα. Interestingly, the κB site upstream of BgTLR1 displayed a higher score and lower 
associated P and E values when compared to other upstream κB sites (BgTLR2 and BgIRAK) 
that were shown to bind successfully to BgRHD (Table 4). However, sequence similarity with 
other related transcription factor binding sites does not necessarily imply that the predicted site 
will be functional. In fact, the κB site for BgTLR1 shows 50% similarity with a mouse TLR2 κB 
site (5’GGGAACTTCC-3’) that bound to a nuclear NF-κB protein after exposure to LPS and 
TNF-α (Musikacharoen et al. 2001). In comparison, our EMSA data for predicted κB sites 
reported upstream of BgMyD88 and BgIKKα did not show any binding with the BgRHD. 
Bioinformatics analysis revealed low scores for both κB sites upstream of BgMyD88 and 
BgIKKα (Table 4). Although we were unable to confirm successful binding for these three 
predicted κB sites, other κB sites have been predicted within introns. It is possible that NF-κB 
may regulate the expression of these immune genes, but further EMSAs would need to be done. 
4.2 Sequence alignment of kappa-binding sites in B. glabrata 
 All of the B. glabrata κB sites that have successfully bound to the BgRHD were aligned 
using Vector NTI® (Fig. 16-17). The alignment includes sequences from two upstream binding 
sites (Bgp38 MAPK and BgIκBα) that bound successfully to the same B. glabrata RHD used in 
the present study (Humphries & Harter, 2015). A novel, B. glabrata consensus sequence         
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(5’-GGGAATTTTCC-3’) was generated by aligning all κB sites that bound successfully to the 
BgRHD using MEME-ChIP (http://meme-suite.org/tools/meme-chip) (Fig. 18; Machanick & 
Bailey, 2011). This is the first demonstration of a molluscan consensus sequence for an NF-κB 
binding site. In all eight sequences, the consensus sequence contained a G and C residue within 
the second and tenth positions, respectively (Fig. 18). The 5’ terminal G nucleotides and 3’ 
terminal C residues displayed within the consensus sequences have been shown to be essential 
for facilitating protein-DNA interactions in other invertebrate species (Mrinal et al. 2011). 
Additionally, highly conserved T nucleotides are reported within the second half of our 
consensus sequence, which are characteristic of activator sequences in Drosophila melanogaster 
(Mrinal et al. 2011). Perhaps these κB sites are involved in initiating gene regulation. 
Furthermore, when comparing sequences that did not bind specifically to BgRHD to those that 
did bind, we see two major differences (Fig. 16). We observe a G in the fourth position in two of 
the three sequences. Additionally, one sequence shows a T residue at both the ninth and tenth 
positions. Both are characteristics that were not seen in any of the probes that showed positive 
binding. This implies that these particular positions are important in determining binding to the 
BgRHD. 
 Our consensus sequences can be compared to that of the vertebrate consensus sequence, 
which reads as 5’-GGGRNYYYCC-3’, where R is a purine (A or G), Y is a pyrimidine (T or C), 
and N is any nucleotide (Chen et al. 1998). It is not surprising that our B. glabrata consensus 
sequences exhibits a high degree of similarity with the vertebrate consensus sequence, given that 
other studies have shown that the BgRHD can exhibit cross reactivity with vertebrate κB sites 
(Jiang & Wu, 2007; Humphries & Harter, 2015).  
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 Perhaps this new B. glabrata consensus sequence can be used to create a new 
transcription factor binding site search algorithm that is better at predicting κB sites within 
immune genes of the snail. This would allow for the unique opportunity to search large genomic 
sequences with a much higher degree of specificity. Additionally, the use of this consensus 
sequence could help to search for binding sites within other invertebrate species. 
4.3 Challenges with the available transcription factor binding site search algorithms 
 In this study, the identification of putative binding sites is based on sequence similarity 
but the matrices used to predict these conserved sites come from vertebrate studies. In order to 
improve the available search engines, additional functional studies need to be done within 
invertebrates to characterize binding sites. Subsequently confirmed binding sites would be useful 
for creating a new search engine that is trained specifically within invertebrate species, such as 
B. glabrata, Caenorhabditis elegans, and D. melanogaster.  
4.4 Further research 
 This research project could be expanded in several ways in order to build upon our 
understanding of the regulatory mechanisms for molluscan NF-κB activity. Future studies might 
include a focus on the prediction of κB sites downstream of the stop codon, as downstream κB 
sites have been characterized in vertebrate models (Xie et al. 1994; Rahman et al. 1999). I have 
begun preliminary bioinformatics analysis by searching 2000 bp downstream of the stop codon 
for several members of the NF-κB pathway, including BgIκBβ, BgNF-κB p105, and BgNF-κB 
p65. Two putative κB sites for IκBβ (5’-GGGAAATACT-3’ and 5’-GGGGACCCCCC-3’) were 
reported downstream of the stop codon, but no potential binding sites were predicted for either 
BgNF-κB p105 or BgNF-κB p65.  
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 Additionally, information from the generated B. glabrata consensus sequence gives us an 
initial insight into the determination of which nucleotides might play a role in facilitating 
successful binding interactions with the BgRHD. In order to expand upon our knowledge of 
these sequence specific interactions, a series of single nucleotide substitutions could be 
performed to generate new oligonucleotide probes that resemble the B. glabrata consensus 
sequence. After modifying specific residues, e.g., G2  C2, we could use EMSAs to determine if 
the mutation could prevent or inhibit protein-DNA binding. Functional studies done by Mrinal et 
al. (2011) have generated a T6  A6 mutation in the D. melanogaster binding site shown 
upstream of IκB and found that the activator function was switched to that of a repressor. An 
additional study done by Muroi et al. (1993) indicated that a nucleotide switch at the same 
position showed a similar transformation from an enhancer to a repressor. 
 We could also use EMSAs to determine if NF-κB translocates to the nucleus following 
exposure to a PAMP, e.g. PGN or S. mansoni larval products. Preliminary work has been done 
via immunoblot assays and immunocytochemistry to investigate NF-κB nuclear translocation 
using nuclear extracts from the B. glabrata embryonic (Bge) cell line. If NF-κB can be induced 
to locate to the nucleus, nuclear fractions containing the native BgNF-κB, rather than the 
recombinant BgRHD, could be used in EMSAs. 
 In conclusion, the characterization of six novel κB sites upstream of BgTLR2, BgIRAK, 
BgIκBβ, BgNF-κB p105, BgNF-κB p65, and BgLITAF has helped to elucidate whether NF-κB 
may be able to regulate members of the TLR pathway in B. glabrata. Additionally, we report the 
discovery of the first molluscan consensus sequence for an NF-κB binding site. Furthermore, the 
binding of the κB sites by the BgRHD in EMSAs supports that the B. glabrata NF-κB p65 
homologue may function as a transcription factor. Based on our overall findings, we hypothesize 
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that NF-κB may regulate selective components of the TLR pathway. However, further work 
needs to be done to understand these regulatory processes in the snail, especially due to its 
crucial interaction with the schistosome parasite.  
 47 
 
WORKS CITED 
Adema, C.M., Hertel, L.A., Miller, R.D., & Loker, E.S. (1997). A family of fibrinogen-related 
proteins that precipitates parasite-derived molecules is produced by an invertebrate after 
infection. Proc Natl Acad Sci. 94(16): 8691-8696. 
Adema, C.M., Hanington, P.C., Lun, C., Rosenberg, G.H., Aragon, A.D., Stout, B.A., Lennard-
Richard, M.L., Gross, P.S., & Loker, E.S. (2009). Differential transcriptomic responses of 
Biomphalaria glabrata (Gastropoda, Mollusca) and metazoan parasites, Schistosoma 
mansoni and Echinostoma paraensei (Digenea, Platyhelminthes). Mol Immunol. 47(4): 
849-860.   
Adema, C.M., Anderson, K.V., Bayne, C.J., Belvin, M.P., Buckley, P.M., et al. (2016). Whole 
genome analysis of Biomphalaria glabrata (Lophotrochozoa), a snail intermediate host for 
schistosomiasis. Science. Manuscript in review. 
Altschul, S.F., Gish, W., Miller, W., Meyers, E.W., & Lipman, D.J. (1990). Basic local 
alignment search tool. J Mol Biol. 215(3): 403-410. 
Bayne, C.J., Buckley, P.M., & DeWan, P.C. (1980). Schistosoma mansoni: Cytotoxicity of 
hemocytes from susceptible snail hosts for sporocysts in plasma from resistant 
Biomphalaria glabrata. Exp Parasitol. 50(3): 409-416. 
Bulet, P., Stocklin, R., & Menin, L. (2004). Anti-microbial peptides: From invertebrates to 
vertebrates. Immunol Rev. 198: 169-184. 
Bunje, P. (2003). “The Mollusca: Sea slugs, squid, snails, and scallops.” Berkeley 
http://www.ucmp.berkeley.edu/taxa/inverts/mollusca/mollusca.php 
Boros, D.L. (1989). Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev. 
2(3): 250-269.  
Brown, K., Park, S., Kanno, T., Franzoso, G., & Siebenlist, U. (1993). Mutual regulation of the 
transcription activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci. 
90(6): 2532-2536. 
Centers for Disease Control and Prevention. (2012). Parasites – Schistosomiasis. Retrieved from 
http://www.cdc.gov/parasites/schistosomiasis/ 
Chen, F.E., Huang, D.B., Chen, Y.G., & Ghosh, G. (1998). Crystal structure of p50/p65 
heterodimer of transcription factor NF-κB bound to DNA. Nature. 391(6665): 410-413. 
Chen, F.E. & Ghosh, G. (1999). Regulation of DNA binding by Rel/NF-κB transcription factors: 
Structural views. Oncogene. 18(49): 6845-6852. 
 48 
 
Colley, D.C., Bustinduy, A.L., Secor, W.E., & King, C.H. (2014). Human schistosomiasis. 
Lancet. 383(9936): 2253-2264. 
Cornet, V., Henry, J., Corre, E., Le Corguille, G., & Zatylny-Gaudin, C. (2015). The Toll/NF-κB 
pathway in cuttlefish symbiotic accessory nidamental gland. Dev Comp Immunol. 53(1): 
42-46. 
Cui, J.G., Li, Y., Zhao, Y., Bhattacharjee, S., & Lukiw, W.J. (2010). Differential regulation of 
interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and 
NF-κB in stressed human astroglial cells and in Alzheimer disease. J Biol Chem. 285(50): 
38951-38960. 
De Martin, R., Vanhove, B., Cheng, Q., Hofer, E., Csizmadia, V., Winkler, H., & Bach, F.H. 
(1993). Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene 
is regulated by NF kappa B. EMBO J. 12(7): 2773-2779. 
Franzenburg, S., Fraune, S., Kunzel, S., Baines, J.F., Domazet-Loso, T., & Bosch, T.C. (2012). 
MyD88-deficient Hydra reveal ancient function of TLR signaling in sensing bacterial 
colonizers. PNAS. 109(47): 19374-19379. 
Gauthier, M. & Degnan, B.M. (2008). The transcription factor NF-kappaB in the demosponge 
Amphimedeon queenslandsica: Insights on the evolutionary origin of the Rel homology 
domain. Dev Genes Evol. 218(1): 23-32. 
Geertz, M. & Maerkl, S.J. (2010). Experimental strategies for studying transcription factor-DNA 
binding specificities. Brief Funct Genomics. 9(506): 362-373. 
Gilmore, T.D. & Wolenski, F.S. (2012). NF-κB: Where did it come from and why? Immunol 
Rev. 246(1): 14-35. 
Glinski, Z. & Jarosz, J. (1997). Molluscan immune defenses. Arch Immunol Ther Exp (Warsz). 
45(2-3): 149-155. 
Goodall, C.P., Bender, R.C., Broderick, E.J., & Bayne, C.J. (2004). Constitutive differences in 
Cu/Zn superoxide dismutase mRNA levels and activity in hemocytes of Biomphalaria 
glabrata (Mollusca) that are either susceptible or resistant to Schistosoma mansoni 
(Trematoda). Mol Biochem Parasitol. 137(2): 321-328. 
Goodson, M.S., Kojadinovic, M., Troll, J.V., Schetz, T.E., Casavant, T.L., Soares, M.B., & 
McFall-Ngai, M.J. (2005). Identifying components of the NF-κB pathway in the beneficial 
Euprymna scolopes-Vibrio fischeri organ symbiosis. Appl Environ Microbiol. 71(11): 
6934-6946. 
Gray, D.J. (2011). Diagnosis and management of schistosomiasis. BMJ. 342: d2651-d2662. 
 49 
 
Gryseels, B., Polman, K., Clerinx, J., & Kestens, L. (2006). Human schistosomiasis. Lancet. 
368(9541): 23-29. 
Guillou, F., Mitta, G., Galinier, R., & Coustau, C. (2007). Identification and expression of gene 
transcripts generated during an anti-parasitic response in Biomphalaria glabrata. Dev 
Comp Immunol. 31(7): 657-671. 
Hahn, U.K., Bender, R.C., & Bayne, C.J. (2001). Killing of Schistosoma mansoni sporocyts by 
hemocytes from resistant Biomphalaria glabrata: Role of reactive oxygen species. J 
Parasitol. 87(2): 292-299. 
Hanington, P.C., Forys, M.A., Dragoo, J.W., Zhang, S.M., Adema, C.M., & Loker, E.S. (2010). 
Role for a somatically diversified lectin in resistance of an invertebrate to parasite 
infection. PNAS. 107(49): 21087-21092. 
He, C.B., Wang, Y., Liu, W.D., Gao, X.G., Chen, P.H., Li, Y.F., & Bao, X.B. (2013). Cloning, 
promoter analysis and expression of the tumor necrosis-associated factor 6 (TRAF6) in 
Japanese scallop (Mizuhopecten yessoensis). Mol Biol Res. 40(8): 4769-4779. 
Hellman, L.M. & Fried, G. (2007). Electrophoretic mobility shift assay (EMSA) for protein-
nucleic acid interactions. Nat Protoc. 2(8): 1849-1861. 
Hinkle, J.L. & Bowman, L. (2003). Neuroprotection for ischemic stroke. J Neurosci Nurs. 35(2): 
114-118. 
Humphries, J.E. & Yoshino, T.P. (2008). Regulation of hydrogen peroxide release in circulating 
hemocytes of the planorbid snail Biomphalaria glabrata. Dev Comp Immunol. 32(5): 554-
562.  
Humphries, J. & Harter, B. (2015). Identification of nuclear factor-kappaB (NF-κB) binding 
motifs in Biomphalaria glabrata. Dev Comp Immunol. 53(2): 366-370. 
Iwanaga, S. & Lee, B.L. (2005). Recent advances in innate immunity of invertebrate animals. J 
Biochem Mol Biol. 38(2): 128-150. 
Jiang, Y.S. & Wu, X.S. (2007). Characterization of a Rel\NF-κB homologue in a gastropod 
abalone, Haliotis diversicolor supertexta. Dev Comp Immunol. 31(2): 121-131. 
Johnson, C.M. & Tapping, R.I. (2007). Microbial products stimulate human Toll-like receptor 2 
expression through histone modification surrounding a proximal NF-kappaB-binding site. J 
Biol Chem. 282(43): 31197-31205. 
Kawai, T. & Akira, S. (2006). TLR signaling. Cell Death Differ. 13: 816-825. 
 50 
 
Kurtz, J. & Franz, K. (2003). Evidence for memory in invertebrate immunity. Nature. 425(6953): 
37-38. 
Lee, C. & Huang, C.H. (2014). LASAGNA-Search 2.0: Integrated transcription factor binding 
site search and visualization in a browser. Bioinformatics. 30(13): 1923-1925. 
Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.C., & Hoffman, J.A. (1996). The 
dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal 
response in Drosophila adults. Cell. 86(6): 973-983. 
Liang, Y., Zhong, Y., & Shen, P. (2004). NF-κB and its regulation on the immune system. Cell 
Mol Immunol. 1(5): 343-350. 
Little, T.J., Read, A.F., & Hultmark, D. (2005). Invertebrate immunity and the limits of 
mechanistic immunology. Nat Immunol. 6(7): 651-654. 
Lockyer, A.E., Emery, A.M., Kane, R.A., Walter, A.J., Mayer, C.D., Mitta, G., Coustau, C., 
Adema, C.M., Hanelt, B., Rollinson, D., Noble, L.R., & Jones, C.S. (2002). Early 
differential gene expression in haemocytes from resistant and susceptible Biomphalaria 
glabrata strains in response to Schistosoma mansoni. PLoS ONE. 7(12): e51102. 
Lodish, H., Berk, A., Zipursky, S.L, Matsudaira, P., Baltimore, D., & Darnell, J. (2000). 
Molecular Cell Biology (4th ed.). New York, NY: W.H. Freeman and Company. 
Loker, E.S., Adema, C.M., Zhang, S., & Kepler, T.B. (2004). Invertebrate immune systems – not 
homogenous, not simple, not well understood. Immunol Rev. 198: 10-24. 
Lu, R., Moore, P.A., & Pitha, P.M. (2002). Stimulation of IRF-7 gene expression by tumor 
necrosis factor alpha: Requirement for NF-kappaB transcription factor and gene 
accessibility. J Biol Chem. 277(19): 16592-16598. 
Machanick, P. and Bailey, T.L. (2011). MEME-ChIP: Motif analysis of large DNA datasets. 
Bioinformatics, 27(12): 1696-1697. 
Matricon-Gondran, M. & Letocart, M. (1999). Internal defenses of the snail Biomphalaria 
glabrata. J Invertebr Pathol. 74(3): 235-247.  
Mitta, G., Galinier, R., Tisseyre, P., Allienne, J.F., Girerd-Chambraz, Y., Guillou, F., Bouchut, 
A., & Coustau, C. (2005). Gene discovery and expression analysis of immune-relevant 
genes from Biomphalaria glabrata hemocytes. Dev Comp Immunol. 29(5): 393-407. 
Montagnani, C., Kappler, C., Reichhart, J.M., & Escoubas, J.M. (2004). Cg-Rel, the first 
Rel/NF-kappaB homolog characterized in a mollusk, the Pacific oyster Crassostrea gigas. 
FEBS Letters. 561:75-82. 
 51 
 
Montgomery, S.B., Griffith, O.L., Sleumer, M.C., Bergman, C.M., Bilenky, M., Pleasance, E.D., 
Prychyna, Y., Zhang, X., & Jones, S.J.M. (2005). ORegAnno: An open access database and 
curation system for literature-derived promoters, transcription factor binding sites, and 
regulatory variation. Bioinformatics. 22(5): 637-640. 
Moorthy, A.K., Savinova, O.V., Ho, J.Q., Wang, V.Y., Vu, D., & Ghosh, G. (2006). The 20S 
proteasome processes NF-κB1 p105 into p50 in a translational-independent manner. EMBO 
J. 25(9): 1945-1956. 
Moynagh, P.N. (2005). The NF-κB pathway. J Cell Sci. 118: 4389-4392. 
Mrinal, N., Tomar, A., & Nagaruju, J. (2011). Role of sequence encoded κB DNA geometry in 
gene regulation by Dorsal. Nuc Acids Res. 39(22): 9574-9591. 
Muroi, M., Muroi, Y., Yamamoto, K., & Suzuki, T. (1993). Influence of 3’ half-site sequence of 
NF-κB motifs on the binding of lipopolysaccharide-activatable macrophage NF-κB 
proteins. J Biol Chem. 268(26): 19534-19539. 
Musikacharoen, T., Matsuguchi, T., Kikuchi, T., & Yoshikai, Y. (2001). NF-κB and STAT5 play 
important roles in the regulation of mouse Toll-like receptor 2 gene expression. J Immunol. 
166(7): 4516-4524. 
Nowak, T.S., Woodards, A.C., Jung, Y., Adema, C.M., & Loker, E.S. (2004). Identification of 
transcripts generated during the response of resistant Biomphalaria glabrata to 
Schistosoma mansoni infection using suppression subtractive hybridization. J Parasitol. 
90(5): 1034-1040. 
Nyholm, S.V. & Graf, J. (2012). Knowing your friends: Invertebrate innate immunity fosters 
beneficial bacterial symbioses. Nat Rev Microbiol. 10(12): 815-827. 
Owen, J., Pundt, J. & Stranford, S. (2013). Kuby Immunology (7th ed.). New York, NY: W.H. 
Freeman. 
Park, E., Kim, Y., Nam, B., Kong, H., Kim, W., Lee, S., Kong, I., & Choi, T. (2008). Cloning, 
characterization and expression analysis of the gene for a putative lipopolysaccharide-
induced TNF-α factor of the Pacific oyster, Crassostrea gigas. Fish Shellfish Immunol. 
24(1): 11-17. 
Putnam, N.H., Srivastava, M., Hellsten, U., Dirks, B., Chapman, J., Salamov, A., Terry, A., 
Shapiro, H., Lindquist, E., Kapitonov, V.V., Jurka, J., Gentikhovich, G., Griqoriev, I.V., 
Lucas, S.M., Steele, R.E., Finnerty, J.R., Technau, U., Martindale, M.Q., & Rokhsar, D.S. 
(2007). Sea anemone genome reveals ancestral eumetazoan gene repertoire and genomic 
organization. Science. 317(5834): 86-94. 
 52 
 
Rahman, A., Khandaker, N., Anwar, N., True, A.L., & Malik, A.B. (1999). Thrombin-induced 
p65 homodimer binding to downstream NF-κB site of the promoter mediates endothelial 
ICAM-1 expression and neutrophil adhesion. J Immunol. 162(9): 5466-5476. 
Rast, J.P. & Messier-Solek, C. (2008). Marine invertebrate genome sequences and our evolving 
understanding of animal immunity. Biol Bull. 214(3): 274-283. 
Roberts, L., Janovy, J., & Nadler, S. (2012). Foundations of Parasitology (9th ed.). New York, 
NY: McGraw-Hill Education. 
Rowe, S.E. & O’Gara, J.P. (2016). Electrophoretic mobility shift assays. Methods Mol Biol. 
1373: 155-167. 
Rowley, A.F. & Powell, A. (2007). Invertebrate immune systems-specific, quasi-specific, or 
nonspecific? J Immunol. 179(11): 7209-7214. 
Sadd, B.M. & Schmid-Hempel, P. (2006). Insect immunity shows specificity in protection upon 
secondary pathogen exposure. 16(12): 1206-1210. 
Scott, M.L., Fujita, T., Liou, H., Nolan, G.P., & Baltimore, D. (1993). The p65 subunit of NF-κB 
regulates IκB by two distinct mechanisms. Genes Dev. 7: 1266-1276. 
Song, L.S., Wang, L.L., Qiu, L.M., & Zhang, H. (2010). Bivalve Immunity. In K. Söderhäll 
(Ed.), Invertebrate Immununity (pp. 44-65). New York, NY: Springer.  
Sun, S.C., Ganchi, P.A., Ballard, D.W., & Greene, W.C. (1993). NF-kappa B controls expression 
of inhibitor I kappa B alpha: Evidence for an inducible autoregulatory pathway. Science. 
259(5103): 1912-1915. 
Takeshita, F., Suzuki, K., Sasaki, S., Ishii, N., Klinman, D.M., & Ishii, K.J. (2004). 
Transcriptional regulation of the human TLR9 gene. J Immunol. 173(4): 2552-2561. 
Thompson, J.E., Phillips, R.J., Erdjument-Bromage, H., Tempst, P., & Ghosh, S. (1995). IκB-β 
regulates the persistent response in a biphasic activation of NF-κB. Cell. 80(4): 573-582.  
Toubiana, M., Gerdol, M., Rosani, U., Pallavicini, A., Venier, P., & Roch, P. (2013). Toll-like 
receptors and MyD88 adaptors in Mytilus: Complete cds and gene expression levels. Dev 
Comp Immunol. 40(2): 158-166. 
Valenzuela-Munoz, V., Bueno-Ibarra, M.A., & Gallardo-Escarate, C. (2014). Characterization of 
the transcriptomes of Haliotis rufescens reproductive tissues. Aquaculture Res. 45(6): 
1026-1040. 
 
 53 
 
Wan, F., Anderson, D.E., Barnitz, R.A., Snow, A., Bidere, N., Zheng, L., Hedge, V., Lam, L.T., 
Staudt, L.M., Levens, D., Deutsch, W.A., & Lenardo, M.J. (2007). Ribosomal protein S3: 
A KH domain subunit in NF-kappaB complexes that mediates selective gene regulation. 
Cell. 131(5): 927-939. 
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., 
Gabrilovich, D., Heller, R., Coppola, D., Dalton, W., Jove, R., Pardoll, D., & Yu, H. 
(2004). Regulation of the innate and adaptive immune responses by Stat-3 signaling in 
tumor cells. Nat Med. 10(1): 48-54. 
Wang, P.H., Wan, D.H., Pang, L.R., Gu, Z.H., Qiu, W., Weng, S.P., Yu, X.Q., & He, J.G. 
(2012). Molecular cloning, characterization and expression analysis of the tumor necrosis 
factor (TNF) superfamily gene, TNF receptor superfamily gene and lipopolysaccharide-
induced TNF-α factor (LITAF) gene from Litopenaeus vannamei. Dev Comp Immunol. 
36(1): 39-50.  
Wen, A.Y., Sakamoto, K.M., & Miller, L.S. (2010). The role of the transcription factor CREB in 
immune function. J Immunol. 185(11): 6413-6419. 
Wingender, E., Chen, X., Hehl, R., Karas, H., Liebich, I., Matys, V., Meinhardt, T., Prub, M., 
Reuter, I., & Schacherer, F. (2000). TRANSFAC: An integrated system for gene 
expression regulation. Nuc Acids Res. 28(1): 316-319.  
World Health Organization. (1993). Report of the WHO Expert Committee: The control of 
Schistosomiasis. Geneva: WHO. Ser 830. p. 86. 
World Health Organization. (2015). Schistosomiasis, Fact Sheet No 115. Retrieved from 
http://www.who.int/mediacentre/factsheets/fs115/en/ 
Xie, Q., Kashiwabara, Y., & Nathan, C. (1994). Role of transcription factor NF-κB/Rel in 
induction of nitric oxide synthase. J Biol Chem. 269(7): 4705-4708. 
Xiong, K., Feng, Q., Chen, L., Xie, L., & Zhang, R. (2008). Cloning and characterization of an 
IKK homologue from the pearl oyster, Pinctada fucata. Dev Comp Immunol. 32(1): 15-25. 
Yoshino, T.P. & Cousteau, C. (2011). Immunobiology of Biomphalaria – Trematode 
Interactions. In R. Toledo and B. Fried (Eds.). Biomphalaria Snails and Larval Trematodes 
(pp. 159-190). New York, NY: Springer. 
Zhang, G. & Ghosh, S. (2001). Toll-like receptor-mediated NF-kappaB activation: A 
phylogenetically conserved paradigm in innate immunity. J Clin Invest. 107(1): 13-19. 
Zhang, S.M., Zeng, Y., & Loker, E.S. (2008). Expression profiling and binding properties of 
fibrinogen-related proteins (FREPs), plasma proteins from the schistosome snail host 
Biomphalaria glabrata. Innate Immunol. 14(3): 175-189. 
 54 
 
Zhang, S. & Coultas, K.A. (2011). Identification and characterization of five transcription factors 
that are associated with evolutionarily conserved immune signaling pathways in the 
schistosome-transmitting snail Biomphalaria glabrata. Mol Immunol. 48(15-16). 1868-
1881.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 55 
 
APPENDIX 
Appendix I. Bioinformatics analyses for Bgp38 MAPK and BgIκBα. 
Table 6. Identification of putative κB sites within 2000 bp upstream of protein coding regions for 
BgIκBα and Bgp38 MAPK. Length-Alignment Site Guided by Nucleotide Association 2.0 (LASAGNA 2.0) 
data highlighted in blue represents genes and their respective sequences that were selected for further analyses 
in Humphries and Harter’s (2015) study. Sequences in black represent the additional putative κB sites 
identified in the current study. 
Control Region Sequence Number of κB sites 
Bgp38 MAPK cggattttcc 
tggaatttct 
gggaggttcc 
tcggatttcc 
4 
BgIκBα cggaaatccc 
gggcctttcc 
ggaactttct 
gaaatcccct 
4 
 
Appendix II. Troubleshooting guide 
 In principle, an EMSA is a very simple and rapid tool used to test transcription factor 
functionality. However, this assay may require much optimization and a variety of parameters 
typically need to be considered in order to obtain clear gel shifts. More common experimental 
factors can include buffer pH, buffer composition, salinity, and percentage acrylamide (Hellman 
& Fried, 2007). In addition, DNA-protein binding can be disrupted by improper preparation of 
binding reactions. Poly I:C (nonspecific blocker), KCl, 50% glycerol, magnesium chloride 
(MgCl2), and NP-40 (detergent) can all be added in order to optimize the binding reaction. In 
addition, the amount of added protein has the potential to disrupt the binding interactions. An 
excess amount of protein can cause aggregate formation, causing the nucleic acid to become 
stuck in the gel. A troubleshooting guide has been assembled based on my experiences in order 
to help improve optimization and reduce issues that were mentioned above. 
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Table 7. Electrophoretic mobility shift assay troubleshooting guide. This information was compiled based 
on my own experiences troubleshooting the EMSA protocol. 
Problem Possible cause Possible solution 
Bands are smeared or streaked Uneven gel polymerization 
 
Wrong buffer 
 
 
 
Buffer went off 
 
Overheating occurred 
 
 
Protein degraded 
Use fresh gel components. 
 
Switch to TAE buffer and lower 
concentration (0.25 X to 0.5 X) 
 
 
Prepare fresh buffer. 
 
Reduce voltage during transfer or add 
ice pack. 
 
Use fresh protein 
No shift appears Poor transfer 
 
Binding buffer went off 
 
Protein degraded 
 
pH is not optimal 
 
 
Binding interaction was disrupted 
Increase transfer time 
 
Prepare fresh binding buffer 
 
Use fresh protein. 
 
Increase buffer pH to promote protein-
DNA binding 
 
Increase incubation time 
Incubate on a rocker 
No visible bands Streptavidin degraded 
 
 
 
 
Inefficient transfer 
 
Samples cannot move from gel to 
membrane due to small pore size 
 
Biotin degraded 
 
 
Perform “dark room test” and add 1 µL 
SA-HRP to solution containing equal 
parts of ECL reagents. 
 
 
Increase transfer time. 
 
Decrease amount of acrylamide in gel. 
 
 
Increase volume of DNA. 
Re-label probes 
Bubbles or wrinkles in gel Excessive heating. Decrease voltage during transfer or add 
an ice pack during transfer. 
Dark bands on membrane. Too much HRP in the system. Decrease amount of SA-HRP added to 
blocking buffer during detection. 
 
 
 
